Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer
出版年份 2012 全文链接
标题
Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer
作者
关键词
-
出版物
BMC CANCER
Volume 12, Issue 1, Pages -
出版商
Springer Nature
发表日期
2012-07-19
DOI
10.1186/1471-2407-12-298
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
- (2011) C. F. Verschraegen et al. ANNALS OF ONCOLOGY
- Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients
- (2011) Nabila Chaher et al. BREAST CANCER RESEARCH AND TREATMENT
- Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
- (2011) Yun Gong et al. CANCER
- Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group
- (2011) Priya Rastogi et al. Clinical Breast Cancer
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer
- (2010) Peter B. Vermeulen et al. CANCER
- Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor–Positive Breast Cancer
- (2010) Mauricio P. Pinto et al. CANCER RESEARCH
- Inflammatory Breast Cancer: Novel Preoperative Therapies
- (2010) Beth A. Overmoyer Clinical Breast Cancer
- Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases
- (2010) Edouard Lecarpentier et al. INVESTIGATIONAL NEW DRUGS
- Histological, Immunohistological, and Ultrastructural Description of Vasculogenic Mimicry in Canine Mammary Cancer
- (2010) M. Clemente et al. VETERINARY PATHOLOGY
- A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers
- (2009) J. Baar et al. CLINICAL CANCER RESEARCH
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- NF-kappa B genes have a major role in Inflammatory Breast Cancer
- (2008) Florence Lerebours et al. BMC CANCER
- Gene Expression Profile and Angiogenic Markers Correlate with Response to Neoadjuvant Bevacizumab Followed by Bevacizumab plus Chemotherapy in Breast Cancer
- (2008) S. X. Yang et al. CLINICAL CANCER RESEARCH
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
- Pathologic Aspects of Inflammatory Breast Cancer: Part 2. Biologic Insights Into Its Aggressive Phenotype
- (2008) Yun Gong SEMINARS IN ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started